Archive for February, 2009
Another Cancer Drug Bites the Dust?
Synta Pharmaceuticals' grand dreams fall apart over safety issues with a new melanoma medicine.
Going All In For Wynn
The high-end gaming and hospitality play is the class of the casino lot even though it had a horrible quarter.
Henry Schein Clips 2009 Outlook
Medical products supplier curbs expectations, citing a stronger U.S. dollar and weaker customer spending.
Henry Schein Clips 2009 Outlook
The medical products supplier curbed expectations, citing a stronger U.S. dollar and weaker customer spending.
Walking The Vytorin Tightrope
Researchers worried about a cancer risk for the blockbuster heart drug for a year.